Thus, antiaggressive effects of some medications (other
than clozapine) may be mediated by their influence on
cognitive functions. These functions should therefore
be assessed at baseline and then at various time points
during trials of antiaggressive treatments in schizophrenia
patients. The apparent difference between clozapine
and olanzapine in the mechanism of antiaggressive action
is intriguing and merits further investigation.